Environmental Services · Founded 2012 · www.bankabio.com · NSE · ISIN INE862Y01015
No Notes Added Yet
1. Business Overview
Banka Bioloo Ltd. is an Indian environmental services company primarily engaged in providing sustainable sanitation and waste management solutions. Its core business revolves around designing, manufacturing, supplying, installing, and maintaining bio-digester-based human waste management systems, commonly known as bio-toilets. The company's solutions utilize anaerobic microbial technology to convert human waste into reusable water and biogas, eliminating the need for extensive sewage infrastructure. Banka Bioloo caters to various clients including Indian Railways, government departments, public sector undertakings, corporations, and individual users, generating revenue from product sales, project execution, and ongoing maintenance services.
2. Key Segments / Revenue Mix
Banka Bioloo's primary revenue driver is its range of bio-toilet and bio-digester systems. While specific revenue mix percentages are not consistently and explicitly broken down into detailed segments in public disclosures, the company's offerings broadly include:
Bio-toilets & Bio-digesters: The flagship product line for various applications (railway coaches, public spaces, schools, remote areas, disaster relief).
Greywater Treatment Systems: Solutions for treating wastewater from non-toilet sources.
Solid Waste Management: Limited or project-specific involvement in decentralized solid waste management.
The majority of revenue is derived from the supply and installation of bio-toilets and related sanitation infrastructure projects.
3. Industry & Positioning
The company operates within India's rapidly growing Environmental Services sector, specifically focusing on sanitation and waste management. The industry is significantly influenced by government initiatives like the Swachh Bharat Abhiyan (Clean India Mission), which drives demand for sustainable and decentralized sanitation solutions. The market is fragmented, with numerous local players, contractors, and some larger companies. Banka Bioloo has carved a niche by specializing in bio-digester technology, having gained experience with large-scale deployments, notably with Indian Railways. It positions itself as a technology-driven provider of eco-friendly and cost-effective sanitation, rather than a generic waste management firm.
4. Competitive Advantage (Moat)
Banka Bioloo's competitive advantages are primarily:
Specialized Technology: Expertise in DRDO-licensed (Defence Research and Development Organisation) bio-digester technology for human waste treatment, potentially with proprietary improvements or adaptations.
Project Execution Capability: Proven track record in executing large-scale, complex projects, particularly with demanding clients like Indian Railways, which requires specific certifications and operational capabilities.
Early Mover Advantage (Niche): Being among the early and recognized players in promoting and implementing bio-toilet solutions in India has given it experience and visibility in this specific niche.
Network/Client Relationships: Established relationships with key government bodies and large institutional clients built over years of project delivery.
5. Growth Drivers
Government Initiatives: Continued push from "Swachh Bharat Abhiyan 2.0" and other government programs promoting hygiene, sanitation, and sustainable waste management in rural and urban areas.
Infrastructure Development: Demand for decentralized sanitation solutions in new infrastructure projects, smart cities, and remote locations where conventional sewage systems are unfeasible.
Environmental Awareness: Increasing public and corporate awareness regarding environmental protection and sustainable practices, leading to greater adoption of eco-friendly solutions.
ESG Compliance: Corporate sector's growing focus on ESG (Environmental, Social, and Governance) factors could drive demand for sustainable sanitation solutions for their facilities and CSR initiatives.
Technology Adoption: Expanding acceptance and adoption of bio-digester technology as a viable, low-maintenance alternative to traditional septic tanks and sewage systems.
6. Risks
Dependence on Government Projects: A significant portion of revenue is likely derived from government tenders and contracts, making the company susceptible to policy changes, funding cycles, and project delays.
Intense Competition: The market is competitive, with local contractors, other bio-toilet manufacturers, and larger infrastructure players bidding for projects, which can pressure margins.
Regulatory & Policy Changes: Any changes in environmental regulations or sanitation policies could impact demand or necessitate costly technology upgrades.
Technology Adoption Barriers: Resistance to adopting new sanitation technologies, operational challenges, or perceived high upfront costs in certain segments.
Working Capital Management: Projects often require significant working capital, and delays in payments from government entities can strain liquidity.
7. Management & Ownership
Banka Bioloo is promoted by Mr. Sanjay Banka and Mrs. Namita Banka. Mr. Sanjay Banka serves as the Managing Director and is instrumental in the company's strategic direction and technological development. It is primarily a promoter-driven company, characteristic of many small and mid-cap Indian firms. The ownership structure reflects a significant holding by the promoter family, with the remaining shares held by the public and other institutional investors.
8. Outlook
Banka Bioloo operates in a fundamentally growing market driven by India's vast sanitation needs and strong government impetus. Its specialized technology and experience in executing large-scale projects, particularly with Indian Railways, provide a strong foundation. The continued focus on sustainable sanitation, smart cities, and ESG initiatives presents significant growth opportunities. However, the company faces inherent risks associated with dependence on government contracts, intense competition, and the need for efficient working capital management in a project-based business. Success will hinge on its ability to diversify its client base, innovate its offerings, maintain cost competitiveness, and scale its operations effectively amidst a dynamic policy environment.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 11 | 14 | 16 | 13 | 12 | 14 | 15 | 11 | 13 | 15 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Total Income | 12 | 14 | 16 | 13 | 12 | 14 | 15 | 12 | 13 | 15 |
| Total Expenditure | 9 | 12 | 15 | 11 | 17 | 14 | 15 | 11 | 13 | 14 |
| Operating Profit | 2 | 2 | 1 | 2 | -4 | 0 | -0 | 1 | 0 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | -0 | 0 | -6 | -1 | -2 | -0 | -2 | -0 |
| Provision for Tax | -0 | -0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Profit After Tax | 1 | 1 | -0 | 0 | -6 | -1 | -2 | -0 | -1 | -0 |
| Adjustments | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Profit After Adjustments | 1 | 1 | -0 | 0 | -6 | -1 | -2 | 0 | -1 | -0 |
| Adjusted Earnings Per Share | 1.1 | 0.6 | -0.2 | 0.3 | -5.6 | -1.3 | -1.5 | 0 | -1 | -0.1 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Net Sales | 48 | 30 | 39 | 42 | 50 | 54 | 54 |
| Other Income | 0 | 1 | 0 | 1 | 0 | 0 | 1 |
| Total Income | 48 | 31 | 39 | 43 | 50 | 55 | 55 |
| Total Expenditure | 39 | 27 | 33 | 36 | 46 | 57 | 53 |
| Operating Profit | 9 | 4 | 6 | 7 | 4 | -3 | 3 |
| Interest | 1 | 2 | 2 | 2 | 3 | 4 | 4 |
| Depreciation | 0 | 1 | 1 | 1 | 2 | 3 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit Before Tax | 8 | 2 | 3 | 4 | -1 | -9 | -4 |
| Provision for Tax | 2 | -0 | 0 | 1 | 0 | -0 | 0 |
| Profit After Tax | 6 | 2 | 3 | 3 | -1 | -9 | -3 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | 6 | 2 | 3 | 3 | -1 | -9 | -3 |
| Adjusted Earnings Per Share | 6.1 | 2.1 | 2.9 | 2.3 | -0.6 | -8.2 | -2.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 8% | 11% | 2% | 0% |
| Operating Profit CAGR | -175% | NAN% | NAN% | 0% |
| PAT CAGR | 0% | NAN% | NAN% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 19% | 3% | -0% | NA% |
| ROE Average | -25% | -7% | -1% | 3% |
| ROCE Average | -8% | 2% | 5% | 8% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Shareholder's Funds | 28 | 30 | 38 | 40 | 40 | 32 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 7 | 6 | 7 | 5 | 11 | 12 |
| Other Non-Current Liabilities | 1 | 1 | 2 | 2 | 1 | 1 |
| Total Current Liabilities | 11 | 9 | 17 | 18 | 25 | 38 |
| Total Liabilities | 47 | 46 | 64 | 65 | 77 | 82 |
| Fixed Assets | 4 | 5 | 7 | 11 | 15 | 16 |
| Other Non-Current Assets | 8 | 5 | 5 | 7 | 13 | 13 |
| Total Current Assets | 35 | 36 | 53 | 47 | 49 | 53 |
| Total Assets | 47 | 46 | 64 | 65 | 77 | 82 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | -0 | -0 | 3 | 3 | 1 | 0 |
| Cash Flow from Operating Activities | -6 | 6 | -0 | 7 | 3 | 1 |
| Cash Flow from Investing Activities | -1 | -0 | -3 | -6 | -10 | -6 |
| Cash Flow from Financing Activities | 7 | -4 | 1 | -3 | 7 | 5 |
| Net Cash Inflow / Outflow | 1 | 2 | -2 | -2 | -1 | -0 |
| Closing Cash & Cash Equivalent | 0 | 2 | 0 | 1 | 0 | 0 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 6.06 | 2.14 | 2.87 | 2.34 | -0.6 | -8.2 |
| CEPS(Rs) | 6.51 | 2.73 | 3.73 | 3.71 | 1.4 | -5.87 |
| DPS(Rs) | 1 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 27.26 | 29.21 | 34.57 | 36.97 | 36.5 | 28.56 |
| Core EBITDA Margin(%) | 15.78 | 9.67 | 12.43 | 12.7 | 6.3 | -4.51 |
| EBIT Margin(%) | 15.76 | 9.6 | 11.4 | 11.11 | 3.37 | -8.45 |
| Pre Tax Margin(%) | 14.25 | 5.24 | 7.4 | 7.43 | -0.96 | -14.43 |
| PAT Margin (%) | 11.31 | 6.18 | 6.95 | 5.21 | -1.15 | -14.09 |
| Cash Profit Margin (%) | 12.16 | 7.86 | 9.05 | 8.25 | 2.59 | -10.09 |
| ROA(%) | 13.31 | 4.73 | 5.63 | 3.93 | -0.94 | -11.17 |
| ROE(%) | 22.22 | 7.6 | 9.2 | 6.54 | -1.68 | -25.22 |
| ROCE(%) | 21.98 | 8.55 | 10.8 | 9.94 | 3.3 | -8.2 |
| Receivable days | 99.26 | 136.35 | 130.71 | 162.06 | 142.92 | 146.54 |
| Inventory Days | 24.95 | 60.34 | 87.46 | 103.67 | 70.23 | 40.65 |
| Payable days | 132.86 | 272.33 | 166.89 | 224.24 | 79.5 | 107.23 |
| PER(x) | 3.87 | 27.86 | 28.5 | 29.78 | 0 | 0 |
| Price/Book(x) | 0.86 | 2.05 | 2.36 | 1.89 | 2.56 | 2.54 |
| Dividend Yield(%) | 1.71 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.65 | 2.15 | 2.6 | 2.08 | 2.47 | 2 |
| EV/Core EBITDA(x) | 3.41 | 16.28 | 16.73 | 12.77 | 29.46 | -42.95 |
| Net Sales Growth(%) | 0 | -36.37 | 27.23 | 9.29 | 18.06 | 8.36 |
| EBIT Growth(%) | 0 | -60.52 | 48.88 | 6.25 | -63.54 | -370.38 |
| PAT Growth(%) | 0 | -64.59 | 40.95 | -18.3 | -126.43 | -1227.48 |
| EPS Growth(%) | 0 | -64.59 | 33.6 | -18.3 | -125.7 | -1262.77 |
| Debt/Equity(x) | 0.41 | 0.35 | 0.44 | 0.37 | 0.63 | 1.1 |
| Current Ratio(x) | 3.22 | 3.92 | 3.07 | 2.56 | 1.95 | 1.41 |
| Quick Ratio(x) | 2.87 | 3.04 | 2.28 | 1.78 | 1.62 | 1.25 |
| Interest Cover(x) | 10.46 | 2.2 | 2.85 | 3.02 | 0.78 | -1.41 |
| Total Debt/Mcap(x) | 0.47 | 0.17 | 0.18 | 0.2 | 0.24 | 0.43 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.2 | 52.72 | 52.72 | 52.62 | 52.62 | 52.44 | 52.38 | 52.23 | 52.2 | 52.07 |
| FII | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 46.8 | 47.25 | 47.28 | 47.38 | 47.38 | 47.56 | 47.62 | 47.77 | 47.8 | 47.93 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.58 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.08 | 1.08 | 1.08 | 1.08 | 1.08 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.2 | 52.72 | 52.72 | 52.62 | 52.62 | 52.44 | 52.38 | 52.23 | 52.2 | 52.07 |
| FII | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 46.8 | 47.28 | 47.28 | 47.38 | 47.38 | 47.56 | 47.62 | 47.77 | 47.8 | 47.93 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.58 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.08 | 1.08 | 1.08 | 1.08 | 1.08 | 1.09 | 1.09 | 1.09 | 1.09 | 1.09 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +8% | +11% | +2% | — |
| Operating Profit CAGR | -175% | 0% | 0% | — |
| PAT CAGR | — | 0% | 0% | — |
| Share Price CAGR | +19% | +3% | 0% | — |
| ROE Average | -25% | -7% | -1% | +3% |
| ROCE Average | -8% | +2% | +5% | +8% |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.